FDA “Delayering” Initiative Reorganizes Office of Commissioner

The Center for Devices & Radiological Health already meets FDA's agency-wide "delayering" goals and will likely be exempted from further restructuring, according to device center staffers

More from Archive

More from Medtech Insight